ACCURAY INCORPORATED Payments for Royalties
ACCURAY INCORPORATED (ARAY) reported Payments for Royalties of $1.27 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRoyalties · last filed 2026-08-27
- ACCURAY INCORPORATED payments for royalties for the quarter ending 2026-06-30 was -$103.00K, a 123.04% decline year-over-year.
- ACCURAY INCORPORATED payments for royalties for the quarter ending 2026-03-31 was $982.00K, a 167.57% increase year-over-year.
- ACCURAY INCORPORATED payments for royalties for the quarter ending 2025-12-31 was $11.00K, a 80.70% decline year-over-year.
- ACCURAY INCORPORATED payments for royalties for the quarter ending 2025-09-30 was $378.00K, a 46.15% decline year-over-year.
- ACCURAY INCORPORATED payments for royalties for fiscal 2026 was $1.27M, a 19.39% decline from fiscal 2025.
- ACCURAY INCORPORATED payments for royalties for fiscal 2025 was $1.57M, a 14.73% increase from fiscal 2024.
- ACCURAY INCORPORATED payments for royalties for fiscal 2024 was $1.37M.
| Period end | Payments for Royalties 3 month | Payments for Royalties 6 month | Payments for Royalties 9 month | Payments for Royalties 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $879.00K derived: sum of 2 quarters · filed 2026-08-27 | $890.00K derived: sum of 3 quarters · filed 2026-08-27 | $1.27M 10-K · filed 2026-08-27 |
| 2026-03-31 | $982.00K 10-Q · filed 2026-05-06 | $993.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.37M 10-Q · filed 2026-05-06 | $1.82M derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-12-31 | $11.00K 10-Q · filed 2026-02-17 | $389.00K 10-Q · filed 2026-02-17 | $836.00K derived: sum of 3 quarters · filed 2026-08-27 | $1.20M derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-09-30 | $378.00K 10-Q/A · filed 2026-02-17 | $825.00K derived: sum of 2 quarters · filed 2026-08-27 | $1.19M derived: sum of 3 quarters · filed 2026-08-27 | $1.25M derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-06-30 | $447.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $814.00K derived: sum of 2 quarters · filed 2026-08-27 | $871.00K derived: sum of 3 quarters · filed 2026-08-27 | $1.57M 10-K · filed 2026-08-27 |
| 2025-03-31 | $367.00K 10-Q · filed 2026-05-06 | $424.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.13M 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $57.00K 10-Q · filed 2026-02-17 | $759.00K 10-Q · filed 2026-02-17 | ||
| 2024-09-30 | $702.00K 10-Q/A · filed 2026-02-17 | |||
| 2024-06-30 | $1.37M 10-K/A · filed 2026-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |